Regenerative Medicine and Stem Cells Technologies

In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could radically improve the treatment for cardiovascular disease, which causes more than a quarter of all deaths in the UK (.

The primary cause of the loss of functionality in transplanted pancreatic islets is their low capacity to create new vessels to transport nutrients. Researchers from the University of Barcelona and IDIBAPS have led a study that identifies a protein as the potential modulator in the revascularization of pancreatic islets.

For the first time, scientists have been able to study how well synthetic bone grafts stand up to the rigors and strains of life, and how quickly they help bone re-grow and repair.

DGIST research team succeeded in developing stem cell delivery of scaffold1 microrobot that can precisely deliver cells to a target body tissue.

Scientists believe they may have found a way to stop the common cold as instead of attacking the virus directly, researchers could target an essential protein found inside our cells which the viruses require to replicate.

The thymus is the powerhouse producing the immune systems T cells, which combat infection in our body. Yet this vital organ is one of the first to diminish in function as we age, resulting in a gradual loss of T cell production and eventually increased susceptibility to infections and cancer in the elderly.

New research by cell biologists at the University of Toronto provides significant new insight into the very first step stem cells go through to turn into the specialized cells that make up organs.

Scientists at The University of Toledo investigating improvements to a commonly used chemotherapy drug have discovered an entirely new class of cancer-killing agents that show promise in eradicating cancer stem cells.

Our brains are notoriously bad at regenerating cells that have been lost through injury or disease. While therapies using neural stem cells (NSCs) hold the promise of replacing lost cells, scientists need to better understand how NSCs behave in the brain in order to develop effective treatments.

Mesenchymal stem cells (MSCs) are a promising form of therapy for acute respiratory distress syndrome (ARDS). The objective of this study was two‐fold: (a) to characterize cytokine expression in serum from ARDS subjects receiving MSCs and (b) to determine MSC function following “preconditioning” with ARDS serum.